The Senate of the US state of Texas has unanimously passed SB 1834 by Senator Glen Hegar (Republican, city of Katy), the first of a series of bills before the legislature calling for transparency in contracts between the state and pharmacy benefit managers. The bill follows a national trend led by the nation's top employers and numerous other states.
CSHB 3454 by Representative Bill Callegari (Republican, Houston) is an omnibus PBM transparency contracting bill that follows standards developed by a coalition of senior human resource executives representing nearly every major industry in the US, including Dell, Home Depot and Caterpillar.
The problem with PBMs now is they strayed from their original purpose of saving prescription drug costs for their clients into money-making middlemen. "They keep much of the negotiated price breaks for themselves, and do so without our knowledge," said Rep Callegari.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze